Insulet, Lilly Team on New Version of OmniPod
Diabetes patients may one day have a new alternative to managing their condition as a result of an agreement between Insulet and Eli Lilly.
Under the agreement, the two will work on a new version of Insulet's OmniPod tubeless insulin delivery system, designed to deliver Lilly's Humalog 200 units/mL insulin. Humalog U200 is provides the same dose of insulin in half the volume of Lilly's Humalog U100 insulin.
In a statement, Insulet says the delivery system represents an opportunity for diabetes patients with higher insulin requirements to benefit from the improved glycemic control versus multiple daily injections.
No financial details were disclosed. — Elizabeth Hollis